BARLOW CARROLEE received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/24/2025ACC: 0001628280-25-007461
Director
Since Jun 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
5.37K acquired · 5.37K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.37K
Price / share
—
Trade value
—
% of position
31.2%
2/22/2025
17.20K→22.57K
Total
Net shares
+5.37K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2025 | A · Award | +5.37K | — | — | 31.2% | 17.20K | 22.57K |
| Total | +5.37K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5.37K shares
Shares
−5.37K
Strike price
Held after
0.00
Exercisable
—
2/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5.37K shares | 2/22/2025 | D · Disposition | −5.37K | — | 0.00 |